BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 315847)

  • 21. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stimulating effect of B-lymphocytes in mixed cultures on autologous T-lymphocytes in chronic lymphatic leukemia].
    Amadori G; Semenzato G; Tosato F; Gasparotto G
    Boll Ist Sieroter Milan; 1976; 55(2):129-33. PubMed ID: 139155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of cell-surface markers in chronic lymphocytic leukaemia (CLL).
    Rak K; Pecze K; Kiss A; Telek B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):294-300. PubMed ID: 6205953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
    Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
    J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cyclic adenosine monophosphate on the in vitro DNA synthesis in lymphocytes of patients with chronic lymphocytic leukemia.
    Konopka L; Karpowicz M; Rechowicz K; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):697-707. PubMed ID: 6260054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphatic leukaemia.
    Hersey P; Wotherspoon J; Reid G; Gunz FW
    Clin Exp Immunol; 1980 Mar; 39(3):698-707. PubMed ID: 6445798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoregulatory abnormalities in chronic lymphocytic leukemia. I. Correlations of immunoregulatory subpopulations with stage of disease.
    Keller RH; Blake DG; Lyman S; Siebenlist R
    J Clin Lab Immunol; 1981 Nov; 6(3):201-9. PubMed ID: 6461766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PHA stimulation of separated human lymphocyte populations.
    Potter MR; Moore M
    Clin Exp Immunol; 1975 Sep; 21(3):456-67. PubMed ID: 1106926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-lymphocytes in B-cell chronic lymphocytic leukaemia.
    Foa R; Catovsky D; Lauria F; Zafar MN; Galton DA
    Haematologica; 1981 Feb; 66(1):105-16. PubMed ID: 6785161
    [No Abstract]   [Full Text] [Related]  

  • 30. Surface markers and other characteristics of the lymphocyte in chronic lymphocytic leukemia.
    Bentwich Z; Polliack A; Douglas SD
    Isr J Med Sci; 1976; 12(4-5):304-22. PubMed ID: 1084879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. I. Acute lymphocytic leukaemia (ALL).
    Ukaejiofo EO; Sagoe AS; Osunkoya BO
    Afr J Med Med Sci; 1983; 12(3-4):187-95. PubMed ID: 6326553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell surface markers in chronic lymphotic leukaemia.
    Poros A; Mód A
    Acta Med Acad Sci Hung; 1977; 34(3):99-107. PubMed ID: 311131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitogenic stimulation of malignant B cells. Chronic lymphocytic leukaemia: relationship between stimulation and surface phenotype.
    Bloem AC; Bast EJ; Gmelig Meyling FH; DeGast GC; Ballieux RE
    Clin Exp Immunol; 1982 Nov; 50(2):355-9. PubMed ID: 6983937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
    Borella L; Sen L; Casper JT
    J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.
    Yoshizaki K; Nakagawa T; Fukunaga K; Kaieda T; Maruyama S; Kishimoto S; Yamamura Y; Kishimoto T
    J Immunol; 1983 Mar; 130(3):1241-6. PubMed ID: 6600479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells.
    Robèrt KH; Bird AG; Möller E
    Scand J Immunol; 1979; 10(5):447-52. PubMed ID: 232570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunological characterization of human chronic lymphatic leukaemia (author's transl)].
    Barboni F; Rovinetti C; Lombardo M; Beltrandi E; Di Marzio A; Tabacchi P; Di Primio R; Geraci L; Battista P; Torlontano G
    Haematologica; 1979 Apr; 64(2):159-72. PubMed ID: 112007
    [No Abstract]   [Full Text] [Related]  

  • 39. T cells in B cell chronic lymphocytic leukaemia. I. Decreased frequency of T lymphocytes secreting suppressor factor.
    Bloem AC; Clevers JC; Bast EJ; Ballieux RE
    Clin Exp Immunol; 1986 Jan; 63(1):188-93. PubMed ID: 3485483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
    Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
    Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.